STALICLA
- Health
STALICLA Translates its Novel Precision Medicine Approach for Autism Spectrum Disorder into Clinical Development with First Patient in Phase 1b Trial of STP1
Geneva, Switzerland: -First precision therapeutic to be investigated in a biologically defined ASD subpopulation: ASD-Phen1 discovered and clinically validated by STALICLA-…
Read More »